Detecting early response to cyclophosphamide treatment of RIF-1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging
- 11 April 2003
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 16 (2) , 102-111
- https://doi.org/10.1002/nbm.816
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysisNMR in Biomedicine, 2002
- Proton NMR chemical shifts and coupling constants for brain metabolitesNMR in Biomedicine, 2000
- Effects of blood flow modifiers on tumor metabolism observedin vivoby proton magnetic resonance spectroscopic imagingMagnetic Resonance in Medicine, 1996
- Magnetic resonance imaging of the brain: Blood partition coefficient for water: Application to spin‐tagging measurement of perfusionJournal of Magnetic Resonance Imaging, 1996
- Apoptosis in murine tumors treated with chemotherapy agentsAnti-Cancer Drugs, 1995
- Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability ModelMagnetic Resonance in Medicine, 1995
- Contrast-Enhanced Magnetic Resonance Imaging Estimation of Altered Capillary Permeability in Experimental Mammary Carcinomas After X-IrradiationInvestigative Radiology, 1994
- Assessment of Osteosarcoma Response to Preoperative Chemotherapy Using Dynamic FLASH Gadolinium-DTPA-Enhanced Magnetic Resonance MappingInvestigative Radiology, 1992
- Measurement of relative regional tumor blood flow in mice by deuterium NMR imagingMagnetic Resonance in Medicine, 1992
- NMR study of in vivo RIF-1 tumorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1984